• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受促红细胞生成素治疗的透析患者的血流动力学变化及运动耐量

Haemodynamic changes and exercise tolerance in dialysis patients treated with erythropoietin.

作者信息

Jurić M, Rupcić V, Topuzović N, Jakić M, Brlosić R, Rusić A, Karner I, Stipanić S, Kes P

机构信息

Department of Cardiology, Osijek Clinical Hospital, Croatia.

出版信息

Nephrol Dial Transplant. 1995;10(8):1398-404.

PMID:8538932
Abstract

The aim of our study was to evaluate cardiovascular function at rest and during exercise in dialysis patients before and after treatment with Epo and to examine the changes in left ventricular mass as the consequence of treatment for anaemia. We applied echocardiography and radionuclide ventriculography at rest and after exercise in our research. Following treatment with Epo there was a decrease in the initially high cardiac output (CO) and cardiac index (CI) from 7.5 to 6.31/min and from 4.3 to 3.61/min/m2 respectively. No changes were noted in mean diastolic (DPB) and mean blood pressure (MBP), as well as the initially increased peripheral resistance index (TPRi) of 2582.3 +/- 2097.3 dyn-s-cm-5.m2. Nevertheless, end-diastolic (EDV) and end-systolic (ESV) volume were significantly decreased (P < 0.05), but the ejection fraction (EF) remained unchanged (73.9%). The decrease in the mean values for left ventricular mass (LVM) was significant only within the subgroup of dialysed patients who initially had larger left ventricular mass (P < 0.01). The functional capacity of the CV system measured during exercise increased from four metabolic equivalents (METs) to 6 METs (P < 0.01). A significant increase in blood volume was also observed following treatment of anaemia. The haemodynamic consequences of Epo therapy for the treatment of anaemia were quite positive. However, we would like to point out certain concerns regarding the dialysed patients with initially lower values for left ventricular mass and cardiac output, since the patients within this group developed left ventricular hypertrophy and an increase in cardiac output.

摘要

我们研究的目的是评估接受促红细胞生成素(Epo)治疗前后透析患者静息和运动时的心血管功能,并检查贫血治疗后左心室质量的变化。在我们的研究中,我们在静息和运动后应用了超声心动图和放射性核素心室造影。接受Epo治疗后,最初较高的心输出量(CO)和心脏指数(CI)分别从7.5降至6.3升/分钟和从4.3降至3.6升/分钟/平方米。平均舒张压(DPB)、平均血压(MBP)以及最初升高的外周阻力指数(TPRi)2582.3±2097.3达因-秒-厘米-5·平方米均未发生变化。然而,舒张末期容积(EDV)和收缩末期容积(ESV)显著降低(P<0.05),但射血分数(EF)保持不变(73.9%)。仅在最初左心室质量较大的透析患者亚组中,左心室质量(LVM)的平均值下降显著(P<0.01)。运动时测量的心血管系统功能能力从4个代谢当量(METs)增加到6个METs(P<0.01)。贫血治疗后还观察到血容量显著增加。Epo治疗贫血的血流动力学后果相当积极。然而,我们想指出对于最初左心室质量和心输出量较低的透析患者存在的某些担忧,因为该组患者出现了左心室肥厚和心输出量增加。

相似文献

1
Haemodynamic changes and exercise tolerance in dialysis patients treated with erythropoietin.接受促红细胞生成素治疗的透析患者的血流动力学变化及运动耐量
Nephrol Dial Transplant. 1995;10(8):1398-404.
2
The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.促红细胞生成素在慢性肾衰竭中的心血管及血液动力学效应
J Assoc Physicians India. 2000 Mar;48(3):301-6.
3
[TrueFISP MR imaging to determine the influence of hemodialysis on the myocardial functional parameters in patients with terminal renal insufficiency].[采用稳态自由进动磁共振成像技术确定血液透析对终末期肾功能不全患者心肌功能参数的影响]
Rofo. 2004 Mar;176(3):350-6. doi: 10.1055/s-2004-812892.
4
Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.接受重组人促红细胞生成素治疗的血液透析患者的超声心动图检查结果:关于对血流动力学最有益的血细胞比容的建议
Clin Nephrol. 1991 Jan;35(1):35-8.
5
Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.重组人促红细胞生成素纠正贫血后透析患者左心室肥厚的消退
Can J Cardiol. 1990 Jan-Feb;6(1):1-4.
6
Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.长期使用重组人促红细胞生成素治疗贫血的透析尿毒症患者后高心输出量和左心室大小的重新正常化。
Clin Nephrol. 1990 Dec;34(6):272-8.
7
Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.重组人促红细胞生成素(rHuEPO)治疗贫血血液透析患者时的血流动力学及容量变化
Clin Nephrol. 1990 Jun;33(6):293-8.
8
[Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].血液透析患者的左心室肥厚:贫血的重要性
Med Pregl. 2007;60 Suppl 2:155-9.
9
[Hyperthyroidism, therapy with erythropoietin, malnutrition and systolic function in hemodialysis: echocardiography study].[甲状腺功能亢进、促红细胞生成素治疗、营养不良与血液透析中的收缩功能:超声心动图研究]
Recenti Prog Med. 2000 Dec;91(12):632-5.
10
Changes in left ventricular function and mass during serial investigations after valve replacement for aortic stenosis.主动脉瓣狭窄瓣膜置换术后系列检查期间左心室功能和质量的变化
J Heart Valve Dis. 2000 Jul;9(4):583-93.

引用本文的文献

1
Worsening of left ventricular diastolic function during long-term correction of anemia with erythropoietin in chronic hemodialysis patients--an assessment by radionuclide ventriculography at rest and exercise.慢性血液透析患者长期使用促红细胞生成素纠正贫血过程中左心室舒张功能的恶化——静息和运动状态下放射性核素心室造影评估
Int J Card Imaging. 1999 Jun;15(3):233-9. doi: 10.1023/a:1006171626861.